Krishna Institute of Medical Sciences Limited
Nature of Disclosure: Regulatory clarification letter addressed to Bombay Stock Exchange Ltd (BSE) and National Stock Exchange of India Ltd (NSE) regarding a news article.
Key Development: The Company issued a formal denial of a news article published on Dealstreetasia.com dated 25th August 2026 titled "ChrysCapital-backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million".
Specific Denials:
- The Company stated that the contents of the news report are "completely false, baseless, and factually incorrect"
- As of 26th August 2026, the Company has not entered into any agreement or memorandum of understanding (MOU) regarding such acquisition
- The Company has not engaged in any discussions as alleged in the report
Regulatory Compliance:
- The Company confirmed compliance with all applicable disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Committed to making appropriate disclosures regarding any material development, event or information as required under applicable laws and regulations
Parties Involved:
- Krishna Institute of Medical Sciences Limited (Issuer)
- Bombay Stock Exchange Ltd (BSE)
- National Stock Exchange of India Ltd (NSE)
- Dealstreetasia.com (News publisher)
- Renova Hospitals (Subject of acquisition rumor)
- ChrysCapital (Mentioned as backer in news article)
Financial Impact: No financial impact disclosed as the Company denied the existence of any such transaction.
#KIMS #RegulatoryClarification #SEBIDisclosure #M&ARumors #Healthcare